Search company, investor...

Advantek

advantekbiologics.com

Stage

Convertible Note | Alive

Total Raised

$4.4M

Last Raised

$1.2M | 17 yrs ago

About Advantek

Advantek provides therapeutic proteins for the treatment of an array of diseases to patients. The company utilizes blood plasma donated by healthy individuals immunized with the Hepatitis B vaccine and tested negative for HIV, HBV, HCV, and other known viruses, as the starting material to produce safe therapeutic proteins. It also offers a spectrum of antibodies, enzymes, cofactors, antisera, and depleted plasmas used in laboratory research and diagnostics. The company is based In Hong Kong.

Headquarters Location

Unit L, Eighth Floor 41-43 Au Pui Wan Street

Hong Kong,

Hong Kong

852 28696401

Missing: Advantek's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Advantek's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Advantek

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Advantek is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Advantek Patents

Advantek has filed 5 patents.

The 3 most popular patent topics include:

  • Aerobic exercise
  • Automotive suspension technologies
  • C-class destroyers (1913)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/19/2019

9/20/2022

C-class destroyers (1913), River-class destroyers, Medical equipment manufacturers, Manufacturing, Dichomeris

Grant

Application Date

11/19/2019

Grant Date

9/20/2022

Title

Related Topics

C-class destroyers (1913), River-class destroyers, Medical equipment manufacturers, Manufacturing, Dichomeris

Status

Grant

Latest Advantek News

Advantek Acquires LKTT Plastic Technology in Malaysia (Shannon Davis/Solid State Technology)

Jan 16, 2023

Shannon Davis / Solid State TechnologyAdvantek Acquires LKTT Plastic Technology in Malaysia - Advantek, LLC, a provider of highly engineered carrier tape and precision component packaging, today announced the acquisition of LKTT Plastic Technology Sdn. Bhd., a provider of complementary precision packaging based in Malaysia. Advantek Acquires LKTT Plastic Technology in Malaysia was posted by Shannon Davis on Semiconductor Digest. Advantek is headquartered ...

Advantek Frequently Asked Questions (FAQ)

  • Where is Advantek's headquarters?

    Advantek's headquarters is located at Unit L, Eighth Floor, Hong Kong.

  • What is Advantek's latest funding round?

    Advantek's latest funding round is Convertible Note.

  • How much did Advantek raise?

    Advantek raised a total of $4.4M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.